Mediomics, LLC Awarded Phase II Grant From National Institutes of Health (NIH): Receives More Than $1M For Rapid Homogenous Protein Assay Platform Development

ST. LOUIS--(BUSINESS WIRE)--Mediomics, LLC has received an additional $460,000 in a renewal of its 2nd year STTR Phase II grant (R42GM079891) from the National Institute of General Medical Sciences. Since 2007, Mediomics has received over one million dollars of STTR funding to develop its quick and sensitive homogenous PINCER™ protein assay. The major goal of the second year project is to further increase the sensitivity of the biosensor.